Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037]

Detalles Bibliográficos
Autores principales: Deus, Cláudia M., Pereira, Susana P., Cunha-Oliveira, Teresa, Teixeira, José, Simões, Rui F., Cagide, Fernando, Benfeito, Sofia, Borges, Fernanda, Raimundo, Nuno, Oliveira, Paulo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577480/
https://www.ncbi.nlm.nih.gov/pubmed/34454869
http://dx.doi.org/10.1016/j.redox.2021.102117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577480/
https://www.ncbi.nlm.nih.gov/pubmed/34454869
http://dx.doi.org/10.1016/j.redox.2021.102117

Ejemplares similares